Cargando…

Effect of Obesity on Neoadjuvant Systemic Therapy Outcomes in Patients with Early Breast Cancer: A Retrospective Institutional Study

BACKGROUND: Obesity and overweight are usually considered as poor prognostic factors in early breast cancer. Body mass index (BMI) is a significant predictive factor for lower pathologic complete response (pCR) rates after neo-adjuvant systemic therapy (NST). The relationship between obesity and bre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rasmy, Ayman, Sorour, Yasser
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437318/ https://www.ncbi.nlm.nih.gov/pubmed/32212794 http://dx.doi.org/10.31557/APJCP.2020.21.3.683

Ejemplares similares

Neoadjuvant systemic therapy for breast cancer
por: Zaborowski, Alexandra M, et al.
Publicado: (2023)

107P Impact of COVID-19 pandemic on breast cancer neoadjuvant therapy: A retrospective institutional analysis
por: Baptista Freitas, M.C., et al.
Publicado: (2022)

Diagnostics and Therapeutics in Early Stage Breast Cancer Receiving Neoadjuvant Systemic Therapy
por: Belli, Paolo, et al.
Publicado: (2023)

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy
por: Miller, Elizabeth, et al.
Publicado: (2014)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder, Tara, et al.
Publicado: (2021)

Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab
por: Gollamudi, Jahnavi, et al.
Publicado: (2016)

Analysis of neoadjuvant chemotherapy for breast cancer: a 20-year retrospective analysis of patients of a single institution
por: Chen, Danzhi, et al.
Publicado: (2023)

Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy
por: Walsh, Elaine M., et al.
Publicado: (2018)

Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study
por: Gori, Stefania, et al.
Publicado: (2023)

Rapid response of breast cancer to neoadjuvant intramammary testosterone-anastrozole therapy: neoadjuvant hormone therapy in breast cancer
por: Glaser, Rebecca L., et al.
Publicado: (2014)

The NeST (neoadjuvant systemic therapy in breast cancer) study – Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer
por: Irwin, G.W., et al.
Publicado: (2019)

Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals
por: Mamounas, Eleftherios, et al.
Publicado: (2016)

Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice
por: Angelucci, Domenico, et al.
Publicado: (2012)

Prognostic factors and clinical outcomes of breast cancer patients with disease progression during neoadjuvant systemic therapy
por: Ling, Yun-xiao, et al.
Publicado: (2023)

Effect of neoadjuvant therapy on breast cancer biomarker profile
por: Rey-Vargas, Laura, et al.
Publicado: (2020)

Novel computational biology modeling system can accurately forecast response to neoadjuvant therapy in early breast cancer
por: Peterson, Joseph R., et al.
Publicado: (2023)

Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy
por: Acevedo, Francisco, et al.
Publicado: (2022)

Outcomes of Early-stage Glottic Carcinoma Treated with Radiation Therapy: A Single Institution Experience
por: AlQahtani, Mubarak, et al.
Publicado: (2018)

State of the art in neoadjuvant therapy of breast cancer
por: Minckwitz, Gunter von, et al.
Publicado: (2013)

Recent advances in neoadjuvant therapy for breast cancer
por: Potter, David A, et al.
Publicado: (2021)

Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity
por: Suppan, Christoph, et al.
Publicado: (2021)

The Effect of Obesity on Response to Neoadjuvant Therapy in Locally Advanced Gastric Cancer
por: Sakin, Aysegul, et al.
Publicado: (2020)

Early prediction of pathological outcomes to neoadjuvant chemotherapy in breast cancer patients using automated breast ultrasound
por: Wang, Xinguang, et al.
Publicado: (2016)

The Effect of Neoadjuvant Therapy on Early Complications of Esophageal Cancer Surgery
por: Rajabi Mashhadi, Mohammadtaghi, et al.
Publicado: (2015)

Retrospective review of total neoadjuvant therapy
por: Babar, Laila, et al.
Publicado: (2019)

Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.
por: Gazet, J. C., et al.
Publicado: (1996)

Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer
por: Marcus, David M., et al.
Publicado: (2013)

Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
por: Cao, Lifen, et al.
Publicado: (2021)

The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer
por: Terman, Elizabeth, et al.
Publicado: (2023)

The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast Cancer
por: Terman, Elizabeth, et al.
Publicado: (2023)

Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response
por: Boughdad, Sarah, et al.
Publicado: (2020)

Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic
por: Park, Ko Un, et al.
Publicado: (2021)

Effectiveness and Safety of Zercepac and Reference Trastuzumab in the Neoadjuvant Setting for Early-Stage Breast Cancer: A Retrospective Cohort Study
por: Liu, Zheying, et al.
Publicado: (2022)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010)

Pathologic Evaluation of Breast Cancer after Neoadjuvant Therapy
por: Park, Cheol Keun, et al.
Publicado: (2016)

Neoadjuvant Therapy in Nonmetastatic Breast Cancer in Kurdistan, Iraq
por: Namiq, Karez Sarbast, et al.
Publicado: (2023)

Pathological responses and survival outcomes in patients with locally advanced breast cancer after neoadjuvant chemotherapy: a single-institute experience
por: Shohdy, Kyrillus S., et al.
Publicado: (2021)

How We Treat Localized Rectal Cancer—An Institutional Paradigm for Total Neoadjuvant Therapy
por: Roeder, Falk, et al.
Publicado: (2022)

Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment
por: Ribeiro, J., et al.
Publicado: (2013)

Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
por: Agostinetto, Elisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kqkl3vp1e10mcc8ltf112vi9gq